SEC Form 4 · accession 0001181431-15-005801
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Hastings
Director
Period of report
Apr 10, 2015
Accepted (ET)
Apr 14, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2015 | M | 2,500 | $13.98 | A | 3,353 | D | |
| Common Stock | Apr 10, 2015 | S | 2,500 | $88.00 | D | 853 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $13.98 | Apr 10, 2015 | M | 2,500 | D | — | Jun 2, 2021 | Common Stock | 2,500 | 5,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2The options vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011.